Illumina Lowers Q2 Revenue Forecast Due to Order Delays | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina announced after the close of the market Wednesday that it expects to report second-quarter revenue of approximately $161 million instead of between $168 million and $173 million as previously forecast.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.